Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Naphthofuran derivatives with potential beta-adrenolytic activity].

L Garuti, A Ferranti, G Giovanninetti

    Il Farmaco; Edizione Scientifica
    |July 1, 1983
    PubMed
    Summary

    Naphtho[1,2-b]furan and naphtho[2,3-b]furan derivatives exhibit low beta-adrenergic blocking activity. Unlike related compounds, they do not produce active metabolites, and larger aromatic systems reduce biological activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The challenge of diagnosing atheroembolic renal disease clinical features and prognostic factors. Circulation 116: 298-304, 2007.

    Clinical journal of the American Society of Nephrology : CJASN·2023
    Same author

    Polo-like kinases inhibitors.

    Current medicinal chemistry·2012
    Same author

    Irreversible protein kinase inhibitors.

    Current medicinal chemistry·2011
    Same author

    Non-ATP competitive protein kinase inhibitors.

    Current medicinal chemistry·2010
    Same author

    [Stress in auto-transportation sector between prejudice and reality].

    Giornale italiano di medicina del lavoro ed ergonomia·2009
    Same author

    Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure.

    Journal of pharmaceutical and biomedical analysis·2006

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Organic Synthesis

    Context:

    • Investigating structure-activity relationships of novel beta-adrenergic blocking agents.
    • Exploring the impact of fused aromatic systems on beta-adrenoceptor interactions.
    • Evaluating metabolic pathways of potential beta-adrenergic antagonists.

    Purpose:

    • To synthesize and assess the beta-adrenergic blocking activity of naphtho[1,2-b]furan and naphtho[2,3-b]furan derivatives.
    • To compare the pharmacological profiles of these novel compounds with existing naphtho[2,1-b]furan analogs.
    • To determine the influence of structural modifications, such as the inclusion of an --OCH2-- moiety, on biological activity.

    Summary:

    • 1-(Naphtho[1,2-b]furan-2-yl)-2-(isopropylamino)ethanol (II) and 1-(naphtho[2,3-b]furan-2-yl)-2-(isopropylamino)ethanol (III) demonstrated limited beta-adrenergic blocking effects.
    • These compounds did not yield metabolites with significant beta-adrenoceptor inhibitory properties, contrasting with naphtho[2,1-b]furan derivatives.
    • Incorporating an --OCH2-- group into aromatic systems larger than benzofuran (e.g., bufuralol) resulted in a loss of biological activity.

    Impact:

    • Provides insights into the structural requirements for effective beta-adrenergic blockade.
    • Identifies specific naphthofuran isomers with reduced metabolic activation, potentially influencing pharmacokinetic profiles.
    • Suggests limitations in extending the aromatic core of beta-adrenergic blockers beyond the benzofuran system for maintaining activity.

    Related Experiment Videos